Modern 5-Year Survival of Resectable Esophageal Adenocarcinoma: Single Institution Experience with 263 Patients

Abstract

Nearly half of patients undergoing esophagectomy for adenocarcinoma survive >or=5 years. Improvements in survival are associated with increased detection of early stage disease, and a liberal use of en bloc resection. Nonsurgical treatments should be compared with these contemporary outcomes measures.